TY - JOUR
T1 - Tokyo cognitive assessment for mild cognitive impairment, ToCA-MCI
T2 - Validity and utility in elderly Japanese
AU - Otsuka, Kuniaki
AU - Kubo, Yutaka
AU - Yamanaka, Gaku
AU - Sasaki, Junko
AU - Kikuchi, Tomoko
AU - Saito, Toshie
AU - Cornelissen, Germaine
AU - Uno, Bunpei
PY - 2017
Y1 - 2017
N2 - Objectives: To develop a 20-minute cognitive screening tool of touch-panel type (Tokyo Cognitive Assessment for MCI, ToCA-MCI) to assist paramedical staff and first-line physicians in detecting mild cognitive impairment (MCI), a clinical state that often progresses to dementia, and to assess the reliability and validity of the ToCA-MCI in elderly Japanese subjects. Participants: Subjects were recruited from community-based medical health checks in 2015 and 2016. The ToCA-MCI, the Mini-Mental State Examination (MMSE), the revised version of Hasegawa's Dementia Scale (HDS-R), the Clock Drawing Test (CDT), the Clinical Dementia Rating (CDR) scale, and routine neurophysiological examinations were conducted on 105 elderly subjects. Mild Alzheimer's disease (AD) was found in 5 and MCI in 21 subjects. Among the 79 controls, age-associated cognitive impairment (AACI) affected 22. Measurements: The ToCA-MCI was administered to all participants. Sensitivity and specificity of the ToCA-MCI in detecting MCI were assessed. Results: The ToCA-MCI score was highly correlated with the MMSE (r=0.664, p< 0.0001), HDS-R (r=0.538, p<0.0001), CDT (r=0.437,/p<0.0001), and CDR (r= -0.442, p< 0.0001) scores. The area under the receiver-operator curve (AUC) for predicting MCI by the ToCA-MCI was 0.9581(odds ratio=60.9). Using a cut-off point of 17/18, the ToCA-MCI demonstrated a sensitivity of 92.3% and a specificity of 83.5% in diagnosing MCI. Conclusion: MCI is an evolving and somewhat controversial clinical entity. The ToCA-MCI is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE. The ToCA-MCI could be a useful cognitive test for screening for MCI. It could be recommended for geriatric health screening in the community as a multi-player participation-type screening tool, and for the early detection of MCI in a primary clinical setting.
AB - Objectives: To develop a 20-minute cognitive screening tool of touch-panel type (Tokyo Cognitive Assessment for MCI, ToCA-MCI) to assist paramedical staff and first-line physicians in detecting mild cognitive impairment (MCI), a clinical state that often progresses to dementia, and to assess the reliability and validity of the ToCA-MCI in elderly Japanese subjects. Participants: Subjects were recruited from community-based medical health checks in 2015 and 2016. The ToCA-MCI, the Mini-Mental State Examination (MMSE), the revised version of Hasegawa's Dementia Scale (HDS-R), the Clock Drawing Test (CDT), the Clinical Dementia Rating (CDR) scale, and routine neurophysiological examinations were conducted on 105 elderly subjects. Mild Alzheimer's disease (AD) was found in 5 and MCI in 21 subjects. Among the 79 controls, age-associated cognitive impairment (AACI) affected 22. Measurements: The ToCA-MCI was administered to all participants. Sensitivity and specificity of the ToCA-MCI in detecting MCI were assessed. Results: The ToCA-MCI score was highly correlated with the MMSE (r=0.664, p< 0.0001), HDS-R (r=0.538, p<0.0001), CDT (r=0.437,/p<0.0001), and CDR (r= -0.442, p< 0.0001) scores. The area under the receiver-operator curve (AUC) for predicting MCI by the ToCA-MCI was 0.9581(odds ratio=60.9). Using a cut-off point of 17/18, the ToCA-MCI demonstrated a sensitivity of 92.3% and a specificity of 83.5% in diagnosing MCI. Conclusion: MCI is an evolving and somewhat controversial clinical entity. The ToCA-MCI is a brief cognitive screening tool with high sensitivity and specificity for detecting MCI as currently conceptualized in patients performing in the normal range on the MMSE. The ToCA-MCI could be a useful cognitive test for screening for MCI. It could be recommended for geriatric health screening in the community as a multi-player participation-type screening tool, and for the early detection of MCI in a primary clinical setting.
KW - Cognitive screening tool
KW - Mild cognitive impairment
KW - Multi-player participation-type
KW - ToCA-MCI
KW - Touch-panel type
UR - http://www.scopus.com/inward/record.url?scp=85024106089&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85024106089&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:85024106089
SN - 0289-8020
VL - 38
SP - 579
EP - 621
JO - Therapeutic Research
JF - Therapeutic Research
IS - 6
ER -